Kyrgyzstan

Last Updated 20 October 2021.

4 Vaccines Approved for Use in Kyrgyzstan

• Gamaleya
  Sputnik Light

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 18 countries

  4 trials in 2 countries

  Approval Source: rdif.ru

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 72 countries

  22 trials in 2 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

• Kazakhstan RIBSP
  QazVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  3 trials in 1 country

  Approval Source: biosafety.kz

  Inactivated

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 67 countries

  14 trials in 2 countries

  Approval Source: macaubusiness.com

  Inactivated

0 Vaccines in Clinical Trials in Kyrgyzstan